Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Archives of Gynecology and Obstetrics
|
May 21, 2014
The impact of cigarette smoking and alcohol consumption on sperm parameters and sperm DNA fragmentation (SDF) measured by Halosperm(®)
G Anifandis, T Bounartzi, C I Messini, et al.
Journal of Endocrinological Investigation
|
February 24, 2007
Endothelin-3 and PRL levels in the maternal and fetal circulation at delivery
K Dafopoulos, A Boli, A Kallitsaris, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 8, 2005
Evidence that termination of the estradiol-induced luteinizing hormone surge in women is regulated by ovarian factors
K Dafopoulos, I Mademtzis, P Vanakara, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 24, 2012
Elimination half-life of anti-Müllerian hormone
G Griesinger, K Dafopoulos, N Buendgen, et al.
Cell and Tissue Banking
|
May 4, 2016
Chorionic villi derived mesenchymal like stem cells and expression of embryonic stem cells markers during long-term culturing
E Katsiani, A Garas, C Skentou, et al.
Andrologia
|
March 14, 2014
Sperm DNA fragmentation measured by Halosperm does not impact on embryo quality and ongoing pregnancy rates in IVF/ICSI treatments
G Anifandis, T Bounartzi, C I Messini, et al.
Human Reproduction (Oxford, England)
|
July 2, 2004
Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role
K Dafopoulos, C G Kotsovassilis, S Milingos, et al.
Journal of Assisted Reproduction and Genetics
|
November 6, 2004
FSH time-concentration profiles before and after administration of 0.25 mg cetrorelix in the gnRH-antagonist multiple-dose protocol for ovarian hyperstimulation
G Griesinger, D Finas, A Alisch, et al.
Human Reproduction (Oxford, England)
|
January 25, 2005
Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol
G Griesinger, A Schultze-Mosgau, K Dafopoulos, et al.
Biomed Research International
|
July 16, 2014
Follicular fluid oocyte/cumulus-free DNA concentrations as a potential biomolecular marker of embryo quality and IVF outcome
M Dimopoulou, G Anifandis, C I Messini, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Archives of Gynecology and Obstetrics
|
May 21, 2014
The impact of cigarette smoking and alcohol consumption on sperm parameters and sperm DNA fragmentation (SDF) measured by Halosperm(®)
G Anifandis, T Bounartzi, C I Messini, et al.
Journal of Endocrinological Investigation
|
February 24, 2007
Endothelin-3 and PRL levels in the maternal and fetal circulation at delivery
K Dafopoulos, A Boli, A Kallitsaris, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 8, 2005
Evidence that termination of the estradiol-induced luteinizing hormone surge in women is regulated by ovarian factors
K Dafopoulos, I Mademtzis, P Vanakara, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 24, 2012
Elimination half-life of anti-Müllerian hormone
G Griesinger, K Dafopoulos, N Buendgen, et al.
Cell and Tissue Banking
|
May 4, 2016
Chorionic villi derived mesenchymal like stem cells and expression of embryonic stem cells markers during long-term culturing
E Katsiani, A Garas, C Skentou, et al.
Andrologia
|
March 14, 2014
Sperm DNA fragmentation measured by Halosperm does not impact on embryo quality and ongoing pregnancy rates in IVF/ICSI treatments
G Anifandis, T Bounartzi, C I Messini, et al.
Human Reproduction (Oxford, England)
|
July 2, 2004
Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role
K Dafopoulos, C G Kotsovassilis, S Milingos, et al.
Journal of Assisted Reproduction and Genetics
|
November 6, 2004
FSH time-concentration profiles before and after administration of 0.25 mg cetrorelix in the gnRH-antagonist multiple-dose protocol for ovarian hyperstimulation
G Griesinger, D Finas, A Alisch, et al.
Human Reproduction (Oxford, England)
|
January 25, 2005
Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol
G Griesinger, A Schultze-Mosgau, K Dafopoulos, et al.
Biomed Research International
|
July 16, 2014
Follicular fluid oocyte/cumulus-free DNA concentrations as a potential biomolecular marker of embryo quality and IVF outcome
M Dimopoulou, G Anifandis, C I Messini, et al.
Page
of 4